QR Kodea

Development of a bicistronic anti-CD19/CD20 CAR construct including abrogation of unexpected nucleic acid sequence deletions

To address CD19 loss from lymphoma after anti-CD19 chimeric antigen receptor (CAR) T cell therapy, we designed a bicistronic construct encoding an anti-CD19 CAR and an anti-CD20 CAR. We detected deletions from the expected bicistronic construct sequence in a minority of transcripts by mRNA sequencin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Norris Lam, Richard Finney, Shicheng Yang, Stephanie Choi, Xiaolin Wu, Lauren Cutmore, Jorge Andrade, Lei Huang, Christina Amatya, Margaret Cam, James N. Kochenderfer
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2023-09-01
Saila:Molecular Therapy: Oncolytics
Gaiak:
Sarrera elektronikoa:http://www.sciencedirect.com/science/article/pii/S2372770523000475
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!